Krabbe Disease Market is segmented By Therapeutics (Gene Therapy (PBKR03, etc.), Stem Cell Transplan...
Market Size in USD Mn
CAGR8.7%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 8.7% |
Market Concentration | High |
Major Players | Magenta Therapeutics, Passage Bio, Forge Biologics, Krystal Biotech, Orchard Therapeutics and Among Others |
The Krabbe disease market is estimated to be valued at USD 530.8 Mn in 2025 and is expected to reach USD 951.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032. The increased research and development of therapies for the treatment of the rare genetic disorder Krabbe disease is driving the growth of this market.